SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
|
|
- Lora Quinn
- 5 years ago
- Views:
Transcription
1 SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician GMCN ROYAL WOLVERHAMPTON HOSPITALS The Royal Wolverhampton Hospitals Trust Lung MDT (11-2C-1) /12 Dr Angela Morgan Compliance Self Assessment LUNG MDT 85.2% (23/27) Key Themes Structure and function of the service The named Lead Clinician for the MDT is Dr A J Morgan. The core and extended membership of the MDT is discussed and detailed within our Operational Policy and Annual Report. However, briefly, the MDT consists of the following core members: - Respiratory Consultant - Consultant Clinical Oncologist - Consultant Medical Oncologist - Consultant Cardiothoracic Surgeon - Consultant Radiologist - Consultant Histopathologist/ Cytologist - 2 Clinical Nurse Specialists The MDT meets weekly on Tuesday afternoons at New Cross Hospital, with 51 meetings taking place over the past year. Approximately, 20 patients are reviewed at the meetings each week, and this number is continuing to increase. A total of 685 patients were discussed with 1099 discussions in the lung MDT in 2010 (NB some patients are discussed more than once) compared with 791 discussions in 2008 and 1006 in 2009 Over the past year, there have been 730 new referrals (via Fast Track, Internal, Emergency & Other) Fast Track referrals Internal referrals Emergency & Other referrals The MDT is still struggling to meet the national target of 62 day compliance despite extensive SELF ASSESSMENT REPORT for The Royal Wolverhampton Hospitals Trust - Lung MDT (published: 7th October 2011) Page: 1/7
2 scrutiny on a regular basis. Data has shown that compliance against this measure stood at 74.2% against the national target of 85% - this equates to 24 breaches for the year. Further detailed figures are presented within our Annual Report. The majority of the breaches attributed to RWHT are due to a complex pathway. Common themes for delay include: - Patients having to be admitted for diagnostic investigations. - In-patient's not being well enough to undertake diagnostic investigations. - Multiple diagnostic investigations are being performed due to initial investigations not yielding positive histology. - Clinical Trials are also impacting on the actual treatment dates due to consent process and clinical needs. - Tertiary referrals to RWHT also impact heavily on the Cancer Waits Target. - Intersite referrals are impacting when patients are being dual investigated. The aim of the MDT is to ensure a well co-ordinated, seamless approach of diagnosis, treatment and care planning to patients diagnosed with lung cancer and mesothelioma. The MDT is committed to providing rapid communication to other professionals who may come into contact with the patients throughout their journey. The Royal Wolverhampton Hospital NHS Trust has the following facilities for lung cancer patients- - A two 28 bedded respiratory wards - A purpose built state of the art Heart and Lung Centre- lung cancer clinics and cardiothoracic clinics are held immediately after the MDT on Tuesday afternoons - A purpose built Radiology Department offering interventional radiology such as CT, MRI, CT guided Biopsies, Ultrasound FNA. - - An Endoscopy Unit which carries out Bronchoscopies and pleural biopsies twice a week and now includes an EBUS service - The Deanesly Centre- housing the Oncology clinics, chemotherapy unit and radiotherapy unit - The Macmillan Support and Information Centre available to all patients and carers offering up to date information on benefits and services available to patients diagnosed with lung cancer - A F/u telephone service for all patients with a diagnosis of lung cancer or mesotheliomaappendix thirteen - Monthly support group meetings for patients and carers - Active research group entering patients into a variety of studies, including new chemotherapeutic agents/regimes and management of pleural diseases. Members of the RWHT Lung MDT attend the NSSG meetings. The NSSG met four times in and 100% cover was provided by RWHT. Coordination of care/patient pathways Referrals are made via the GP to the Fast Track Centre as per the standard pathway for patients with suspected lung cancer. All CXR's requested via the GP are checked by dedicated Radiographers. If a CXR is felt to be SELF ASSESSMENT REPORT for The Royal Wolverhampton Hospitals Trust - Lung MDT (published: 7th October 2011) Page: 2/7
3 indicative of lung cancer, the Radiographers will book a CT scan and refer the patient into the Fast Track Centre. Patients identified as having possible lung cancer on the basis of an abnormal X-ray in other departments i.e. Accident and Emergency, are referred into the lung cancer service via the fast track system. In-patients are managed by the respective medical team, and are referred to the appropriate specialist team to assist with the patient management. The Fast Track Team normally contacts patients to offer them an appointment to see the Respiratory Physicians. If this is not acceptable to the patient a second appointment will be offered (ensuring this is within the two week referral time frame). At this time, a CT scan may have already been requested either by the GP or through the radiology department The MDT co-ordinator along with the Fast Track Team will monitor the patients progress relative to the 2 week Fast Track Referral and 31/62 day waiting time target. Referrals to the MDT are managed by the MDT co-ordinator who receives referrals either via the telephone, or proforma's. The MDT discusses and reviews the management of all new patients with suspected lung cancer. Treatment and planning decisions are made on the basis of the individual needs of the patient concerned and according to local and national guidelines. Treatment plans are recorded in the patient's notes and on the Live Somerset Cancer Register. The treatment plan will be discussed with the patient and their families at the next out- patient appointment. The patient can request a copy of the discussion whereby the treatment plan is set out at the consultation. At this consultation, written information is made available to patients and carers to cover their condition and possible treatment options, information about local services, contact numbers and contact with the Clinical Nurse Specialist. It is seen as best practice to book patients into clinic on the same day as the MDT to inform the patients of the discussion; however this is not always possible. Referrals to surgeons often take place in the MDT and supported by a letter at the time of clinic.referrals to the cardiothoracic surgeons will be equitable and fair thus a rota for referral for diagnostic investigations, resections and specialist surgery has been produced. Further communications will be undertaken with the surgical co-ordinator to ensure this process is as seamless and effective as possible and thereby reducing the waiting times for the patients. Referral to Oncology will be carried out via the MDT, and supported both by a proforma and a letter of referral via the clinic. This will be done within 24 hours of the patient being told of their intended treatment plan. An appointment to see the Oncologist will often be within one week. If this cannot be achieved, ad-hoc clinics are established so that patients are not delayed in being seen, or receiving treatment such as chemotherapy or radiotherapy. It is seen as best practice for the patient to be given the appointments in clinic for the oncologists so that patients are aware of dates and have time to plan. Those patients suitable for clinical trials will be discussed with the Oncologist at the first appointment. Research nurses are also present at the first appointment. The MDT works to the agreed Network guidelines. SELF ASSESSMENT REPORT for The Royal Wolverhampton Hospitals Trust - Lung MDT (published: 7th October 2011) Page: 3/7
4 Patient experience Obtaining patient feedback: A patient focus session was carried out with the support group in January This provided the following information - Positive areas: - Information was clear and concise and given at the time of diagnosis - Support from the CNS and medical team - Non clinical information available for carers - Patients and carers feel supported with telephone follow up service Areas for improvement: - Choice of what information to give - Plan of action with dates for appointments Following the group focus session the following actions have been implemented - Pathway of referral to the MSIC - Oncology appointments given the day of diagnosis or within 24 hours - New telephone follow up service offered to patients throughout their journey Patient Satisfaction Survey: The survey was sent out to 43 patients over the period of March The patients surveyed were selected to cover surgery and chemotherapy as treatment modalities. In summary - 49% response rate - Overall majority of responses were either strongly agreed or agreed to - Patients were advised of delays in clinic accordingly - Improvement re: summary of consultation letters offered - Patients feel that treatment options were discussed with them - Comments included impressed with Heart & Lung Centre/Surgical Team The MDT also took part in the National Cancer Patient Experience Programme "2010 National Survey". Conducted by the Quality Health, the survey was designed to monitor National progress on cancer care, following the launch of the Cancer Reform Strategy in The information captured in the survey will be used to help drive local quality improvements. In several areas the Trust scored in the top 20% of the UK hospitals. Areas of outstanding achievement mainly centred on the provision of patient information and support.51 patients responded for lung. Overall the results were positive for the lung team and scores were well SELF ASSESSMENT REPORT for The Royal Wolverhampton Hospitals Trust - Lung MDT (published: 7th October 2011) Page: 4/7
5 above average on the majority of subjects Clinical outcomes/indicators Clinical Lines of Enquiry: The LUCADA data has been presented within the MDT's Annual Report. The MDT has concerns regarding the accuracy of the data, particularly regarding bronchoscopies, CT scans and histological rate. The MDT will work with RWHT's Cancer Services Team in order to improve the quality of the data. This will then enable the MDT to undertake a meaningful analysis of the results. Mortality and Morbidity post within 30 days of treatment: It is seen as best practice to regularly discuss mortality at the MDT if a core member feels it is necessary. At present, individual directorates hold regular Mortality and Morbidity meeting to discuss and collate all deaths. In the respiratory directorate, this is then fed back to the respiratory governance meeting and is a standard item on the agenda. Research and Clinical Trials: 2010 has shown New Cross Hospital to be one of the highest performing centres to recruit patients into clinical trials. RWHT recruitment figures- 1st April st March 2011 Fragmatic= 11 T-frag=1 Time 1=7 MALCS= 7 Fortis-M=6 FUM=17 Boehinger Pro1=2 Meso=5 TCD=4 TOTAL=34 An educational day will take place each year to up date the MDT on new treatments in each modality including new clinical trials. Audits: Audits are undertaken as part of clinical governance and in accordance with NSSG requirements. The following audits are carried out annually SELF ASSESSMENT REPORT for The Royal Wolverhampton Hospitals Trust - Lung MDT (published: 7th October 2011) Page: 5/7
6 - GP Communication - Patient satisfaction survey, the Trust is also taking part in the "Cancer Patient Experience Survey Programme" Pathway audit/ day audit- see annual review plan In , the MDT also completed the following audits: The Role of Bronchoscopy in Diagnosing Lung Cancer, Endobronchial Ultrasound Audit, Lung Cancer Surgical Resection Audit The network audits as proposed in the lung NSSG Work Plan 2010/2011 are: - Radical radiotherapy Audit- the final part of the data has been received and the audit is to be presented at the NSSG meeting - Surgical Resection Rate Audit- This is still ongoing As part of the GMCN, RWHT are also due to take part in the EGFR and PET Audits. Good Practice Good Practice/Significant Achievements Key Achievements: - 100% attendance at NSSG meetings by a member of the core team at RWHT - Appointment of a new respiratory consultant and lead for lung cancer - 51 Lung MDT meetings held in High recruitment into NCRN trials - Extensive access for patients to new drugs in development through commercial trials - Collaborative working across all modalities of care including introduction of defined surgical referral pathway to ensure equitable distribution of cases amongst surgical colleagues. - Full integration into the MDT of Somerset Cancer Register to collect live data - Collection of data for NLCA (National Lung Cancer Audit) - Annual Education and Review Meeting held at RWHT for the second year running - Ongoing success of patient support telephone calls - Monthly support group now in its second year - Regular involvement of a physiologist for spirometry in the lung cancer clinic, including a dedicated lung function slot each week for patients requiring full lung function testing prior to surgery/ radical radiotherapy - Participation in the local "Early Detection of Lung Cancer" and national "Improving Lung Cancer Outcome Project" - Fully operational with EBUS service at RWHT - Participation in the "National Cancer Patient Experience Programme 2010 National Survey" - Introduction of a fortnightly pleural service at RWHT Concerns Immediate Risks SELF ASSESSMENT REPORT for The Royal Wolverhampton Hospitals Trust - Lung MDT (published: 7th October 2011) Page: 6/7
7 Serious Concerns Concerns General Comments The Lung MDT underwent a formal internal validation peer review assessment (with a properly convened IV panel) on 07/07/11. A full IV report regarding the Lung MDT will be issued by the Trust. Organisational Statement I, Dr Angela Morgan (Lead Clinician) on behalf of ROYAL WOLVERHAMPTON HOSPITALS agree this is an honest and accurate assessment of the Lung MDT. SELF ASSESSMENT REPORT for The Royal Wolverhampton Hospitals Trust - Lung MDT (published: 7th October 2011) Page: 7/7
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician ASWCN TAUNTON AND SOMERSET Taunton Lung MDT (11-2C-1) - 2011/12 Dr Sarah Foster Compliance Self Assessment LUNG MDT
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician NECN NORTH TEES AND HARTLEPOOL North Tees And Hartlepool Lung MDT (11-2C-1) - 2011/12 Dr D N Leitch Compliance Self
More informationLCA Lung Clinical Forum. 21 st October 2014
LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for
More informationPEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)
PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM) Network Organisation (Trust) Team DCN POOLE Poole THYROID ONLY MDT (11-2I-2) - 2011/12 Peer Review Visit Date 18th August 2011 Compliance THYROID ONLY
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT NECN N Tees & Hartlepool North Tees And Hartlepool Date Self Assessment Completed 23rd July 2009 Date of IV Review 19th June 2009
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician CSCCN PORTSMOUTH HOSPITALS Portsmouth Colorectal MDT (11-2D-1) - 2011/12 Daniel OLeary Compliance Self Assessment COLORECTAL
More informationNational Cancer Peer Review Programme
National Cancer Peer Review Programme Julia Hill Acting Deputy National Co-ordinator What is Cancer Peer Review? A quality assurance process for cancer services. An integral part of Improving Outcomes
More informationActivity Report March 2012 February 2013
Lung Cancer Managed Clinical Network Activity Report March 2012 February 2013 John McPhelim Lead Lung Cancer Nurse MCN Clinical Lead Kevin Campbell Network Manager CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MVCN EAST AND NORTH HERTFORDSHIRE Mount Vernon Cancer Centre Cancer Network MDT (11-2K-1) - 2011/12 Date Self Assessment Completed
More informationImproving services for upper GI (OG) cancer Application template (Version 2)
Trust Clinical lead Improving services for upper GI (OG) cancer Application template (Version 2) Managerial lead Date completed 14 June 2013 Barnet & Chase Farm Hospitals NHS Trust Dr Marta Carpani Upper
More informationNational Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer
National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation
More informationACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report
ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY Phases One and Two Final Report July 2017 Introduction This paper presents the learning and actions that have been generated from phase One and Two
More informationNational Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator
National Cancer Peer Review Sarcoma Julia Hill Acting Deputy National Co-ordinator Improving Outcomes Guidance The Intentions of Improving Outcomes for People with Sarcoma Changes in the provision of care
More informationCancer Services Position & Recovery Plan June 2015
Appendix 6 Cancer Services Position & Recovery Plan June 2015 Introduction The Trust is required to achieve 85% compliance for patients on a 62 day pathway from the referral date to the date they receive
More informationACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW
ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW Health Board: Named Health Board contact: Cancer Network: Named contact for Cancer Network: Health Inspectorate Wales contact: Abertawe Bro Morgannwg University
More informationIntegrated Cancer Services Action Plan. Colchester Hospital University NHS Foundation Trust 31 March 2014
Integrated Cancer Services Action Plan Colchester Hospital University NHS Foundation Trust 31 March KEY Implemented, clearly evidenced and externally approved On Track to deliver Some issues narrative
More informationACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW
ACTION PLAN FOLLOWING THE LUNG CANCER PEER REVIEW Health Board: Named Health Board contact: Cancer Network: Named contact for Cancer Network: Health Inspectorate Wales contact: Abertawe Bro Morgannwg University
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2013 March 2014 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationPEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)
PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM) Regional Trauma Network Trauma Centre Trauma Service RMTN Manchester Collaborative MTC Greater Manchester Major Trauma Centre Collaborative Network Organisation
More informationNational Optimal Lung Cancer Pathway
National Optimal Lung Cancer Pathway This document was produced by the Lung Clinical Expert Group 2017 Document Title: National Optimal Lung Cancer Pathway and Implementation Guide Date of issue: August
More informationThere are a number of national guidelines and performance standards which support the implementation of a straight to CT pathway.
December 2015 CONTENTS Contents... 2 1 Introduction... 3 2 Case for Change... 3 3 Evidence... 3 3.1 National and regional policy... 3 3.2 Local audit... 4 4 Supporting Work Initiatives... 5 4.1 Identification
More informationDelivering 62 Day GP Cancer Waits in a Complex Landscape. Hannah Marder Cancer Manager University Hospitals Bristol
Delivering 62 Day GP Cancer Waits in a Complex Landscape Hannah Marder Cancer Manager University Hospitals Bristol Overview The 62 day GP target Cancer pathways What causes breaches? Good practice and
More informationPEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)
PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM) Regional Trauma Network Trauma Centre Trauma Service RMTN Network Organisation Measures (T13-1C-1) - 2013/14 Peer Review Visit Date 29th April 2014 Compliance
More informationThe RAPID Programme Rapid Access to Pulmonary Investigation & Diagnosis
Patient Experience National Network Awards (PENNA) The RAPID Programme 2016-2019 Rapid Access to Pulmonary Investigation & Diagnosis Kath Hewitt Lead Clinical Nurse Specialist Ailsa Rowlands Programme
More informationQuality of Information on CT Brain Request Forms in Memory Service East (MHSOP) 2018/19 Project #1677
Quality of Information on CT Brain Request Forms in Memory Service East (MHSOP) 2018/19 Project #1677 6. Implement change 1. Agree best practice 5. Action plan Action Planning 2. Define methodology Audit
More informationActivity Report April 2012 March 2013
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2012 March 2013 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationNICE Quality Standards and COF
NICE Quality Standards and COF David Baldwin Consultant Respiratory Physician NUH Hon Senior Lecturer Nottingham University Clinical lead NICE lung cancer GL Chair NICE QS Topic Expert Group Quality Standards
More informationUpper GI Cancer Network Site-Specific Group. Work Programme/Service Delivery Plan 2011/14
Upper GI Cancer Network Site-Specific Group Work Programme/Service Delivery Plan 2011/14 1 UPPER GI NSSG Work Programme/Service Delivery Plan AGREEMENT COVER SHEET 2011/14 This Work Programme has been
More informationQuality Standards for Diagnosis and Treatment in Breast Units Across Greater Manchester
Quality Standards for Diagnosis and Treatment in Breast Units Across Greater Manchester Greater Manchester Cancer Clinical Director: Mr Mohammed Absar Pathway Manager: Rebecca Price Pathway approval: 24
More informationActivity Report March 2013 February 2014
West of Scotland Cancer Network Skin Cancer Managed Clinical Network Activity Report March 2013 February 2014 Dr Girish Gupta Consultant Dermatologist MCN Clinical Lead Tom Kane MCN Manager West of Scotland
More informationNational Training Course in Thyroid Ultrasound and FNAC
For endocrinologists and specialists in thyroid disease National Training Course in Thyroid Ultrasound and FNAC Guy s Hospital London, UK British Thyroid Association Course details Dates Friday Venue Robens
More informationCT Colon Service & Radiology Pathways
CT Colon Service & Radiology Pathways Louisa Edwards CT Colon Advanced Radiography Practitioner ABMU 6 th February 2019 Louisa.Edwards@wales.nhs.uk CT, Radiology Dept, POWH, ABMU Health Board Context and
More informationGynae Cancer Multi Disciplinary Team Patient Information
Gynae Cancer Multi Disciplinary Team Patient Information Introduction This booklet is for people who have been diagnosed with gynaecological cancers which include cancer of the cervix, ovary, vulva, vagina
More informationTrust Guideline for the inclusion of women at High Risk of Breast Cancer in the NHS Breast Screening Programme
Trust Guideline for the inclusion of women at High Risk of Breast Cancer in the NHS Breast Screening Programme For Use in: By: For: Division responsible for document: Key words: Name and job title of document
More informationActivity Report April 2012 March 2013
Colorectal Cancer Managed Clinical Network Activity Report April 2012 March 2013 Paul Horgan Professor of Surgery MCN Clinical Lead Kevin Campbell Network Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationmaking a referral for breast imaging Standard Operating Procedure
Document Control Title Reporting Radiographer Author Directorate Surgery Date Version Issued 0.1 May 2016 Status Draft Author s job title Reporting Radiographer Department Breast Imaging Comment / Changes
More informationAcute Oncology Martin Eatock Consultant Medical Oncologist NICaN Medical Director
Acute Oncology 2014 Martin Eatock Consultant Medical Oncologist NICaN Medical Director Patients admitted with cancer have a longer than average stay Berger et al. Clin Medicine (2013) Questions If your
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks Sarcoma National Managed Clinical Network Activity Report April 2013 March 2014 Dr Jeff White Consultant Oncologist NMCN Clinical Lead Lindsay Campbell
More informationActivity Report April 2012 to March 2013
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2012 to March 2013 Professor Roy Rampling Emeritus Professor
More informationA06/S(HSS)b Ex-vivo partial nephrectomy service (Adult)
A06/S(HSS)b 2013/14 NHS STANDARD CONTRACT FOR EX-VIVO PARTIAL NEPHRECTOMY SERVICE (ADULT) PARTICULARS, SCHEDULE 2 THE SERVICES, A - SERVICE SPECIFICATION Service Specification No. Service Commissioner
More informationWhat is Cancer? Treatment. What is a MDT meeting?
i If you need your information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 or send an email to: customercare@ salisbury.nhs.uk You are entitled
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Sarcoma Specialist Multi Disciplinary Team for Suspected Sarcoma of Soft Tissue Extremities (limbs and trunk
More informationBriefing Paper. Single Cancer Pathway
Briefing Paper Single Cancer Pathway Author: Tom Crosby, Clinical Director, Wales Cancer Network Owner: Wales Cancer Network Date: 27 th November 2017 Version: 1.0 Publication/ Distribution: Wales Cancer
More informationLung cancer timed clinical pathways
Lung cancer timed clinical pathways December 2017 1 Context This document sets out best practice timed clinical pathways for lung cancer. It is anticipated that all Cancer Alliances will audit against
More informationHaemato-oncology Clinical Forum. 20 th June 2013
Haemato-oncology Clinical Forum 20 th June 2013 Welcome Dr Majid Kazmi, LCA Haemato-oncology Pathway Group Chair Purpose of today Provide an update on progress of the LCA to date Identify priorities for
More informationSkull Base Tumour Service. The Multi-Disciplinary Team (MDT) Explained. Jan 2018 v1
Skull Base Tumour Service The Multi-Disciplinary Team (MDT) Explained Jan 2018 v1 Skull base tumours grow in the bones of the skull that form the bottom of the head and the body ridge between the nose
More informationActivity Report April 2012 March 2013
Gynaecological Cancer Managed Clinical Network Activity Report April 2012 March 2013 Nadeem Siddiqui MCN Clinical Lead Kevin Campbell Network Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION 4 2.
More informationRuth Howkins Deputy National Coordinator National Cancer Peer Review
Ruth Howkins Deputy National Coordinator National Cancer Peer Review Purpose of Peer Review To ensure services are as safe as possible To improve the quality and effectiveness of care To improve the patient
More informationImproving Outcomes for People with Sarcoma
NHS National Institute for Health and Clinical Excellence Guidance on Cancer Services Improving Outcomes for People with Sarcoma List of All Recommendations March 2006 Developed for NICE by the National
More informationTable 1 Standards and items to set up a PCU: general requirements and critical mass
Table 1 Standards and items to set up a PCU: general requirements and critical mass General requirements and European Prostate Cancer Units are structures managing sufficient volumes of patients with on-site
More informationWork Programme/Service Delivery Plan 2010/2013
Essex and East Suffolk Gynaecological Cancer Network Site Specific Group Work Programme/Service Delivery Plan 2010/2013 Version Number 1.2 Author Members of the NSSG Date Written June 2010 Reviewed May
More informationOne Stop Prostate Biopsy Protocol Author Consultation Date Approved
One Stop Prostate Biopsy Protocol Author Consultation Date Approved Urology Nurse Practioner PROTOCOL FOR MEN ATTENDING A ONE STOP PROSTATE BIOPSY CLINIC RATIONALE Prostate cancer is the most common cancer
More informationINTERNAL VALIDATION REPORT...
INTERNAL VALIDATION REPORT... Network Trust Team AngCN CAMBRIDGE UNIVERSITY HOSPITALS Addenbrookes Sarcoma Locality Measures (11-1D-1l) - 2011/12 Date Self Assessment Completed 30th November 2011 Date
More informationAnnual Report Skin MDT
Annual Report Skin MDT University Hospitals Bristol NHS Foundation Trust 0117 923 0000 Minicom 0117 934 9869 www.uhbristol.nhs.uk Agreement and Approval Skin MDT Lead Clinician David DeBerker Date 29/08/2012
More informationAn Analysis of Results for the Norwood. Operation at Evelina London Children s Hospital (ELCH)
An Analysis of Results for the Norwood Operation at Evelina London Children s Hospital (ELCH) 2012-2015 1 Introduction This report addresses the concerns raised by the 2012-2015 National Congenital Heart
More informationColorectal Cancer Pathway Clinical Subgroup Tuesday 4 th September pm 4 pm CTCCU Seminar Room UHSM
Manchester Cancer Colorectal Cancer Pathway Clinical Subgroup Tuesday 4 th September2014 2 pm 4 pm CTCCU Seminar Room UHSM Attendance Sarah Duff Michael Braun David Bisset Mohammed Sadat Deborah Hitchen
More informationStreamlining the lung diagnostic pathway (A87)
Streamlining the lung diagnostic pathway (A87) Crawley CCG with Surrey and Sussex Healthcare NHS Trust Evaluation January 2017 Summary A new Straight-to-CT pathway for patients with an abnormal CXR result
More informationSupra Network Sarcoma Advisory Group (SAG) Annual Report
London and South East Sarcoma Network Supra Network Sarcoma Advisory Group (SAG) Annual Report 2011-2012 Hosted by Date: December 2012 Version: 2 Review Date: September 2013 London Cancer Integrated Cancer
More informationActivity Report July 2014 June 2015
Urological Cancers Managed Clinical Network Activity Report July 2014 June 2015 Mr Gren Oades Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION 5
More informationBrain and CNS Clinical Network Group (CNG)
Brain and CNS Clinical Network Group (CNG) Annual Report 2013-2014 This Annual Report has been agreed by: Title Name Date Agreed Brain and CNS CNG Chair CMSCN Cancer Clinical Lead CWW Area Team Medical
More informationNational Standards for Sarcoma Services
National Standards for Sarcoma Services 2009 TABLE OF CONTENTS 1. INTRODUCTION TO THE NATIONAL CANCER STANDARDS...2 2. METHODOLOGY...4 3. FORMAT...4 4. INTRODUCTION TO SARCOMA...5 STANDARDS TOPIC: ORGANISATION...10
More informationCancer Improvement Plan Update. September 2014
Cancer Improvement Plan Update September 2014 1 Contents Page 1. Introduction 3 2. Key Achievements 4-5 3. Update on Independent Review Recommendations 6-13 4. Update on IST Recommendations 14-15 5. Update
More informationNational Standards for Sarcoma Services 2009
National Standards for Sarcoma Services 2009 Crown copyright July 2010 F1101011 Contents 1. Introduction to the National Cancer Standards 2. Methodology 3. Format 4. Introduction to Sarcoma Standards Topic:
More informationActivity Report July 2012 June 2013
Urological Cancers Managed Clinical Network Activity Report July 2012 June 2013 Mr Seamus Teahan Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationCIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board)
CIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board) 1 Governance, Leadership and Planning a) Describe your SCP Programme Board (or equivalent), its membership and
More informationUrology Multi Disciplinary Team Patient Information
Urology Multi Disciplinary Team Patient Information Introduction This booklet is for people who have been diagnosed with urological cancers which include prostate, bladder, kidney, testicular and penile
More informationImproving Cancer Pathways. Mel Warwick Macmillan Cancer Manager / Lead Nurse Aintree University Hospital NHS Foundation Trust
Improving Cancer Pathways Mel Warwick Macmillan Cancer Manager / Lead Nurse Aintree University Hospital NHS Foundation Trust Background Poor / inconsistent 62 day performance, across a number of specialities
More information2010 National Audit of Dementia (Care in General Hospitals)
Royal College of Psychiatrists 2010 National Audit of Dementia (Care in General Hospitals) Organisational checklist results and commentary for: Barking, Havering and Redbridge Hospitals NHS Trust The 2010
More informationGuideline for the Management of Patients Suitable for Immediate Breast Reconstruction
Version History Guideline for the Management of Patients Suitable for Immediate Breast Reconstruction Version Summary of change Date Issued 2.0 Endorsed by the Governance Committee 20.02.08 2.1 Circulated
More informationHead and Neck Cancer
Head and Neck Cancer What Happens Next? Information for patients and carers Introduction You will be looked after by a multidisciplinary team (MDT). This is a group of health professionals with specialist
More informationGuideline for the Follow-up of Patients with Gynaecological Malignancies
Guideline for the Follow-up of Patients with Gynaecological Malignancies Version History Version Date Summary of Change/Process 2.0 20.02.08 Endorsed by the Governance Committee 2.1 18.11.10 Circulated
More informationAnnual Report Lung MDT
Annual Report Lung MDT University Hospitals Bristol NHS Foundation Trust 0117 923 0000 Minicom 0117 934 9869 www.uhbristol.nhs.uk Agreement and Approval Lung MDT Lead Clinician Adam Dangoor Date 27/09/2012
More informationRADIOLOGIST JOB DESCRIPTION. Head of Radiology Department Radiology Manager
RADIOLOGIST JOB DESCRIPTION TITLE: RESPONSIBLE TO: LOCATION: Radiologist Head of Radiology Department Radiology Manager Bay of Plenty District Health Board. Principally at Tauranga Hospital but may be
More informationThe European Board of Urology
Page 1 of 15 The European Board of Urology Sub-specialty certification application: Prostate cancer, A - General information A1 - APPLICATION IDENTIFICATION 1a. Application code blank 1b. EBU internal
More informationWorking with you to make Highland the healthy place to be
Highland NHS Board 2 June 2009 Item 4.3 BREAST CANCER SERVICES COMPLIANCE AGAINST 31 AND 62 DAY TARGETS Report by Derick MacRae, Cancer Service Manager on behalf of Dr Ian Bashford, Medical Director The
More informationStaging Issues: Lung Cancer & Mesothelioma. Mick Peake Clinical Lead, NCIN Chair, Lung SSCRG
Staging Issues: Lung Cancer & Mesothelioma Mick Peake Clinical Lead, NCIN Chair, Lung SSCRG Staging systems Non-Small Cell Lung Cancer (>85%): UICC TNM v6 used until 1.1.10 transition since then to v7
More informationNational Peer Review Report: Wales Paediatric Diabetes 2014
National Peer Review Report: Wales Paediatric Diabetes 2014 An overview of the findings from the 2014 National Peer Review of Paediatric Diabetes Services in Wales 1 Contents 1.0 Introduction... 3 1.1
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Specialist Sarcoma Multi Disciplinary Team for Suspected Bone Sarcoma Version History Version Date Brief Summary
More informationSCAN Skin Group Friday 1 st November 2013
SCAN Skin Group Friday 1 st November 2013 Dermatology Seminar Room, Lauriston Buildings with videolinks to Oncology Seminar Room, Western General Hospital and Borders General Hospital. MINUTES Present
More informationMembersmeet 4th January 2011
Membersmeet 4th January 2011 Dr Kirit Ardeshna Consultant Haematologist & Clinical Lead for the Cancer Centre Martin Lerner Divisional Manager, Cancer Division Lisa Godfrey Programme Director, Macmillan
More informationThe Rosie Hospital, Cambridge (0051)
Human Fertilisation and Embryology Authority Report of Renewal inspection at The Rosie Hospital, Cambridge (0051) Date of Inspection 02.05. 2006 Date of Licence Committee 10 July 2006 1 Contents Key facts
More informationWe need to talk about Palliative Care. Pancreatic Cancer UK
We need to talk about Palliative Care Pancreatic Cancer UK 1. Pancreatic Cancer UK welcomes the opportunity to respond to the Health and Sport Committee s inquiry on palliative care. About Pancreatic Cancer
More informationActivity Report April 2014 March 2015
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2014 March 2015 Dr Avinash Kanodia Consultant Radiologist
More informationSAFE PAEDIATRIC NEUROSURGERY A Report from the SOCIETY OF BRITISH NEUROLOGICAL SURGEONS
SAFE PAEDIATRIC NEUROSURGERY 2001 A Report from the SOCIETY OF BRITISH NEUROLOGICAL SURGEONS SAFE PAEDIATRIC NEUROSURGERY 2001 INTRODUCTION In 1997 the SBNS agreed to the setting up of a task force to
More informationNATIONAL MANAGED CLINICAL NETWORK FOR ADULT NEURO-ONCOLOGY ANNUAL REPORT 2010/11
NATIONAL MANAGED CLINICAL NETWORK FOR ADULT NEURO-ONCOLOGY ANNUAL REPORT 2/11 Hosted by West of Scotland Cancer Network (WoSCAN) North, South East and West of Scotland Cancer Networks Contents Contents...ii
More informationSingle Suspected Cancer Pathway Definitions pathway start date
Single Suspected Cancer Pathway Definitions pathway start date Date: March 2018 Version: 1.2.1 Wales Cancer Owner: Network and Welsh Government Status Published 1 P a g e Purpose of Document This document
More informationSelective Dorsal Rhizotomy (SDR) Scotland Service Pathway
Selective Dorsal Rhizotomy (SDR) Scotland Service Pathway This pathway should to be read in conjunction with the attached notes. The number in each text box refers to the note that relates to the specific
More information2010 National Audit of Dementia (Care in General Hospitals) Guy's and St Thomas' NHS Foundation Trust
Royal College of Psychiatrists 2010 National Audit of Dementia (Care in General Hospitals) Organisational checklist results and commentary for: Guy's and St Thomas' NHS Foundation Trust The 2010 national
More informationSTANDARDS FOR UPPER GI CANCERS 2004
STANDARDS FOR UPPER GI CANCERS 2004 Source: CSCG Title: UPPER GI CANCERS STANDARDS Version: 10/CONSULTATION Page 1 of 33 1. INTRODUCTION TO THE CANCER STANDARDS 1.1 These Cancer Standards replace the previous
More informationBreast Cancer Multi Disciplinary Team Patient Information
Breast Cancer Multi Disciplinary Team Patient Information Introduction This booklet is for people who have been diagnosed with breast cancer. It tells you about the breast multidisciplinary team and other
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More informationBladder Cancer Guidelines
Bladder Cancer Guidelines Agreed by Urology CSG: October 2011 Review Date: September 2013 Bladder Cancer 1. Referral Guidelines The following patients should be considered as potentially having bladder
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical
More information2010 National Audit of Dementia (Care in General Hospitals) North West London Hospitals NHS Trust
Royal College of Psychiatrists 2010 National Audit of Dementia (Care in General Hospitals) Organisational checklist results and commentary for: rth West London Hospitals NHS Trust The 2010 national audit
More informationDESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for
DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for 2008-11 1. Aims, Outcomes and Outputs The National Service Framework Designed to Tackle Renal Disease in Wales sets standards
More informationANNUAL CANCER DELIVERY ACTION PLAN REPORT
AGENDA ITEM 6.4 6 May 2014 ANNUAL CANCER DELIVERY ACTION PLAN REPORT Executive Lead: Medical Director Author: UHB Cancer Lead Clinician/Cancer Lead Manager Contact Details for further information: Maggie
More informationFixing footcare in Sheffield: Improving the pathway
FOOTCARE CASE STUDY 1: FEBRUARY 2015 Fixing footcare in Sheffield: Improving the pathway SUMMARY The Sheffield Teaching Hospitals NHS Foundation Trust diabetes team transformed local footcare services
More informationProgress Review of Five Cancer Services at Colchester Hospital University NHS Foundation Trust
Progress Review of Five Cancer Services at Colchester Hospital University NHS Foundation Trust 1 2 Progress Review of Five Cancer Services at Colchester Hospital University NHS Foundation Trust NHS England
More informationUnless this copy has been taken directly from the Trust intranet site (Pandora) there is no assurance that this is the most up to date version
Policy No: OP90 Version: 1.0 Name of Policy: Cancer Services Operational Policy Effective From: 02/11/2016 Date Ratified 30/11/2015 Ratified Corporate Management Team Review Date 01/11/2017 Sponsor Director
More informationOvarian Cancer Quality Performance Indicators
Ovarian Cancer Quality Performance Indicators Patients diagnosed between October 2013 and September 2016 Publication date 20 February 2018 An Official Statistics publication for Scotland This is an Official
More information